MedTrace Logo

BIOFLOW III Satellite-ELADIS Orsiro Stent System

NCT02029092 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 404

Last updated 2017-09-28

No results posted yet for this study

Summary

This registry is a clinical evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES). It is designed to investigate and collect clinical evidence for the clinical performance and safety of the Orsiro Drug Eluting Stent System in an all-comers patient population in daily clinical practice.

Conditions

Sponsors & Collaborators

  • C.E.M. Biotronik, S.A.

    lead INDUSTRY

Principal Investigators

  • Sonia Martin · CEM BIOTRONIK SA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029092 on ClinicalTrials.gov